Daniel Lewis - Pharm.D.

Dr. Lewis received his bachelor's and Pharm.D. degrees from Duquesne University and followed this by completing a pharmacy practice residency at the University Hospital of Cincinnati. He serves as the pharmacist overseeing the clinical pharmacokinetics service (CPS) at the University of Kentucky Chandler Medical Center. The CPS ensures safe and efficacious dosage regimens through the application of pharmacokinetic/pharmacodynamic principles and the determination of drug serum concentrations. Other responsibilities include coordinating the adverse drug reaction monitoring as well as precepting both students and residents on the pharmacokinetics and anticoagulation service. In addition, Dr. Lewis serves as a clinical pharmacokinetics lecturer in the third professional year curriculum.

Selected Publications/Presentations

• Antimicrobial therapy and pharmacokinetic considerations KSHP Spring Meeting. Louisville, KY May 2006
• Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant Factor VIIa for Refractory Bleeding Following Cardiac Surgery using a Direct Thrombin Inhibitor to Facilitate Cardiopulmonary Bypass in a patient with Heparin-Induced Thrombocytopenia. Pharmacotherapy. 2006 Apr;26(4):569-577.
• Development and implementation of a strategic plan to meet ASHP 2015 goals in an academic medical center ASHP Midyear meeting. Las Vegas NV, December 2005.
• Weant, KA, Smith KM, Lewis DA. Assessment of Prescriber Compliance with Established Heart Failure Guidelines at a Major Medical Center. Hospital Pharmacy 2005; 40 (8): 680-86.
• Lewis DA, Gurram NR, Abraham WT, Akers WS. Effect of nesiritide versus milrinone on patient outcomes in the treatment of acutely decompensated heart failure. Am J Health Syst Pharm. 2003 Aug 15;60 Suppl 4:S16-20.